Unknown

Dataset Information

0

Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.


ABSTRACT:

Background

Cancer patient pathways (CPPs) were implemented in 2015 to reduce waiting time, regional variation in waiting time, and to increase the predictability of cancer care for the patients. The aims of this study were to see if the national target of 70% of all cancer patients being included in a CPP was met, and to identify factors associated with CPP inclusion.

Methods

All patients registered with a colorectal, lung, breast or prostate cancer diagnosis at the Cancer Registry of Norway in the period 2015-2016 were linked with the Norwegian Patient Registry for CPP information and with Statistics Norway for sociodemographic variables. Multivariable logistic regression examined if the odds of not being included in a CPP were associated with year of diagnosis, age, sex, tumour stage, marital status, education, income, region of residence and comorbidity.

Results

From 2015 to 2016, 30,747 patients were diagnosed with colorectal, lung, breast or prostate cancer, of whom 24,429 (79.5%) were included in a CPP. Significant increases in the probability of being included in a CPP were observed for colorectal (79.1 to 86.2%), lung (79.0 to 87.3%), breast (91.5 to 97.2%) and prostate cancer (62.2 to 76.2%) patients (p?ConclusionsThe national target of 70% was met within 1 year of CPP implementation in Norway. Although all patients should have equal access to CPPs, a prostate cancer diagnosis, older age, high level of comorbidity or low income were significantly associated with an increased odds of not being included in a CPP.

SUBMITTER: Nilssen Y 

PROVIDER: S-EPMC7260744 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.

Nilssen Yngvar Y   Brustugun Odd Terje OT   Eriksen Morten Tandberg MT   Haug Erik Skaaheim ES   Naume Bjørn B   Møller Bjørn B  

BMC cancer 20200530 1


<h4>Background</h4>Cancer patient pathways (CPPs) were implemented in 2015 to reduce waiting time, regional variation in waiting time, and to increase the predictability of cancer care for the patients. The aims of this study were to see if the national target of 70% of all cancer patients being included in a CPP was met, and to identify factors associated with CPP inclusion.<h4>Methods</h4>All patients registered with a colorectal, lung, breast or prostate cancer diagnosis at the Cancer Registr  ...[more]

Similar Datasets

| S-EPMC8883731 | biostudies-literature
| S-EPMC8613926 | biostudies-literature
| S-EPMC4727267 | biostudies-other
| S-EPMC11332498 | biostudies-literature
| S-EPMC7708579 | biostudies-literature
| S-EPMC5844538 | biostudies-literature
| S-EPMC6377723 | biostudies-literature
| S-EPMC7188805 | biostudies-literature
| S-EPMC6304319 | biostudies-literature
| S-EPMC6374399 | biostudies-literature